Tablet
Latest Merck & Co., Inc. Patents:
- Assays for resistance to echinocandin-class drugs
- ASSAYS FOR RESISTANCE TO ECHINOCANDIN-CLASS DRUGS
- Assays for resistance to echinocandin-class drugs
- INTEGRIN TARGETING AGENTS AND IN-VIVO AND IN-VITRO IMAGING METHODS USING THE SAME
- Integrin targeting agents and in-vivo and in-vitro imaging methods using the same
Description
FIG. 1 is a top plan view of a tablet showing our new design;
FIG. 2 is a bottom plan view thereof;
FIG. 3 is a front elevational view thereof;
FIG. 4 is a rear elevational view thereof;
FIG. 5 is a left side elevational view thereof;
FIG. 6 is a right side elevational view thereof;
FIG. 7 is a top perspective view thereof, on an enlarged scale; and,
FIG. 8 is a bottom perspective view thereof, on an enlarged scale.
Referenced Cited
Patent History
Patent number: D431076
Type: Grant
Filed: Jul 7, 1999
Date of Patent: Sep 19, 2000
Assignee: Merck & Co., Inc. (Rahway, NJ)
Inventors: Tzyy-Show H. Chen (Princeton Junction, NJ), Thomas G. Nyairo (Norristown, PA), Ashok V. Katdare (Norristown, PA)
Primary Examiner: Antoine Duval Davis
Attorneys: Anthony D. Sabatelli, Melvin Winokur
Application Number: 0/108,431
Type: Grant
Filed: Jul 7, 1999
Date of Patent: Sep 19, 2000
Assignee: Merck & Co., Inc. (Rahway, NJ)
Inventors: Tzyy-Show H. Chen (Princeton Junction, NJ), Thomas G. Nyairo (Norristown, PA), Ashok V. Katdare (Norristown, PA)
Primary Examiner: Antoine Duval Davis
Attorneys: Anthony D. Sabatelli, Melvin Winokur
Application Number: 0/108,431
Classifications